קונבריזה

Ország: Izrael

Nyelv: héber

Forrás: Ministry of Health

Aktív összetevők:

BAZEDOXIFENE AS ACETATE 20 MG

Beszerezhető a:

NEOPHARM LTD

ATC-kód:

G03XC02

Gyógyszerészeti forma:

COATED TABLETS

Az alkalmazás módja:

PER OS

Gyártó:

PFIZER IRELAND PHARMACEUTICALS

Terápiás csoport:

BAZEDOXIFENE

Terápiás javallatok:

CONBRIZA is indicated for the treatment of postmenopausal osteoporosis in women at increased risk of fracture. A significant reduction in the incidence of vertebral fractures has been demonstrated; efficacy on hip fractures has not been established. When determining the choice of CONBRIZA or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefit

Engedély dátuma:

2013-04-01